| Literature DB >> 31372231 |
Sabina Borg1,2, Birgitta Öberg1, Margret Leosdottir3,4, Daniel Lindolm5, Lennart Nilsson6, Maria Bäck1,7.
Abstract
BACKGROUND: Despite its well-established positive effects, exercise-based cardiac rehabilitation (exCR) is underused in patients following an acute myocardial infarction (AMI). The aim of the study was to identify factors associated with non-attendance at exCR in patients post-AMI in a large Swedish cohort.Entities:
Keywords: Acute myocardial infarction; Coronary artery disease; Exercise-based cardiac rehabilitation; Non-attendance; Physiotherapy; Secondary prevention
Year: 2019 PMID: 31372231 PMCID: PMC6660668 DOI: 10.1186/s13102-019-0125-9
Source DB: PubMed Journal: BMC Sports Sci Med Rehabil ISSN: 2052-1847
Fig. 1Flowchart of included patients. Flowchart of patients following an acute myocardial infarction registered in SEPHIA and RIKS-HIA between 2010 and 2016
Included variables
| Individual variables | Structural variables |
|---|---|
| Demographic variables | Type of hospital |
| Body mass index | Distance to hospital |
| Occupational status | |
| Smoking | |
| Previous diseases | |
| Index event and intervention | |
| Left ventricular function | |
| Medication |
Baseline demographics for attenders and non-attenders at exercise-based cardiac rehabilitation, n = 31 297
| Attending exercise-based CR | No | Yes | missing, % | |
|---|---|---|---|---|
| Age (years), mean (SD) | 62.9 (8.3) | 62.0 (8.4) | < 0.001a | 0.0 |
| BMI (kg/m2), mean (SD) | 27.8 (4.5) | 27.7 (4.3) | 0.009a | 3.6 |
| Sex, n (%) | 0.058b | 0.0 | ||
| - Men | 12212 (75.3) | 11219 (74.4) | ||
| - Women | 4002 (24.7) | 3864 (25.6) | ||
| Occupational status, n (%) | < 0.001b | 5.5 | ||
| - Employed | 6152 (40.1) | 6711 (47.2) | ||
| - Retired | 8321 (54.2) | 6810 (47.9) | ||
| - Sick leave | 431 (2.8) | 344 (2.4) | ||
| - Unemployed, student, other | 435 (2.8) | 365 (2.6) | ||
| Smoking status, n (%) | < 0.001b | 2.2 | ||
| - Never smoked | 5002 (31.5) | 5563 (37.8) | ||
| - Ex- smoker > 1 month | 5615 (35.4) | 5455 (37.0) | ||
| - Smoker | 5252 (33.1) | 3718 (25.2) | ||
| Previous diseases, n (%) | ||||
| - AMI | 2853 (17.7) | 1718 (11.4) | < 0.001b | 0.4 |
| - PCI | 2339 (14.5) | 1407 (9.4) | < 0.001b | 0.4 |
| - CABG | 1100 (6.8) | 576 (3.8) | < 0.001b | 0.2 |
| - Diabetes | 3150 (19.5) | 2326 (15.5) | < 0.001b | 0.2 |
| - Hypertension | 7049 (43.8) | 6406 (42.7) | 0.057b | 0.6 |
| - Chronic heart failure | 625 (4.0) | 386 (2.6) | < 0.001b | 3.3 |
| - Stroke | 736 (4.6) | 431 (2.9) | < 0.001b | 0.3 |
| Type of index cardiac event, n (%) | < 0.001b | 0.0 | ||
| - STEMI | 5986 (36.9) | 6279 (41.6) | ||
| - NSTEMI | 10228 (63.1) | 8804 (58.4) | ||
| Type of index cardiac intervention, n (%) | ||||
| - PCI | 13204 (81.4) | 12588 (83.5) | < 0.001b | 0.0 |
| - CABG | 644 (4.0) | 878 (5.8) | < 0.001b | 0.0 |
| Left ventricular function, n (%) | < 0.001b | 13.0 | ||
| - Normal | 9288 (66.5) | 9091 (68.5) | ||
| - Lightly reduced | 2767 (19.8) | 2648 (19.9) | ||
| - Moderate/severely reduced | 1903 (13.6) | 1535 (11.6) | ||
| Medication, n (%) | ||||
| - ACE | 10979 (67.7) | 10313 (68.4) | 0.025b | 0.1 |
| - ARB | 2697 (16.6) | 2613 (17.3) | 0.108b | 0.1 |
| - Anticoagulants | 1014 (6.3) | 805 (5.4) | 0.001b | 0.1 |
| - Other platelet inhibitors | 14951 (92.2) | 13857 (91.9) | < 0.01b | 0.1 |
| - ASA | 15623 (96.4) | 14655 (97.2) | < 0.001b | < 0.1 |
| - Beta-blockers | 14744 (91.0) | 13889 (92.1) | < 0.001b | < 0.1 |
| Statins | 15691 (96.8) | 14809 (98.2) | < 0.001b | < 0.1 |
| Distance to hospital, median (IQR) | 11.3 (4.4–25.3) | 18.3 (5.8–34.3) | < 0.001c | 1.6 |
| Type of hospital, n (%) | < 0.001b | 0.0 | ||
| - University hospital | 3462 (21.4) | 3982 (26.4) | ||
| - County hospital | 7079 (43.7) | 5698 (37.8) | ||
| - District hospital | 5673 (35.0) | 5403 (35.8) | ||
CR cardiac rehabilitation, BMI body mass index, AMI acute myocardial infarction, PCI percutaneous coronary intervention, STEMI ST-elevation myocardial infarction, NSTEMI non-ST-elevation myocardial infarction, CABG coronary artery bypass grafting, ACE angiotensin-converting enzyme, ARB angiotensin receptor blocker, ASA acetylsalicylic acid
aStudent’s t-test
bChi2- test
cWilcoxon test
Fig. 2Association between distance to hospital and non-attendance at exCR. Figure 2 shows the unadjusted association between driving distance from the hospital and non-attendance at exercise-based cardiac rehabilitation
Fig. 3Variable importance in a model with and without distance to hospital as an independent variable. Figure 3 shows the importance of the variables in the regression model, with and without driving distance as an independent variable, for non-attendance at exercise-based cardiac rehabilitation
Logistic regression model with distance to CR-centre included as an independent variable
| Variable | OR | Lower 95% | Upper 95% |
|---|---|---|---|
| Age | 1.00 | 0.90 | 1.10 |
| BMI | 1.05 | 0.99 | 1.11 |
| Sex (female vs male) | 0.85 | 0.80 | 0.90 |
| Occupational status (employed vs retired) | 0.86 | 0.80 | 0.93 |
| Occupational status (sick leave vs retired) | 1.05 | 0.89 | 1.23 |
| Occupational status (unemployed/student/other vs retired | 1.02 | 0.87 | 1.20 |
| Smoking status (smoker vs ex-smoker) | 1.63 | 1.54 | 1.74 |
| Smoking status (never smoked vs ex-smoker) | 0.91 | 0.86 | 0.96 |
| Previous diseases (yes vs no) | |||
| Diabetes | 1.20 | 1.13 | 1.28 |
| Hypertension | 0.94 | 0.89 | 0.98 |
| Chronic heart failure | 1.01 | 0.88 | 1.16 |
| Stroke | 1.37 | 1.21 | 1.55 |
| Acute myocardial infarction (AMI) | 1.19 | 1.08 | 1.31 |
| Percutaneous coronary intervention (PCI) | 1.28 | 1.16 | 1.42 |
| Coronary artery bypass grafting (CABG) | 1.31 | 1.16 | 1.48 |
| Type of index cardiac event and intervention | |||
| STEMI vs NSTEMI | 0.84 | 0.80 | 0.88 |
| PCI (yes vs no) | 0.81 | 0.76 | 0.87 |
| CABG (yes vs no) | 0.55 | 0.49 | 0.62 |
| Distance to hospital (km) | 1.74 | 1.62 | 1.86 |
| Type of hospital (university hospital vs county hospital) | 0.79 | 0.75 | 0.84 |
| Type of hospital (district hospital vs county hospital) | 0.78 | 0.74 | 0.82 |
STEMI ST-elevation myocardial infarction, NSTEMI non-ST-elevation myocardial infarction